These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 2526111

  • 1. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
    Maple PA, Hamilton-Miller JM, Brumfitt W.
    J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
    [Abstract] [Full Text] [Related]

  • 2. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
    O'Hare MD, Felmingham D, Grüneberg RN.
    Drugs Exp Clin Res; 1988 Apr; 14(10):617-9. PubMed ID: 2977587
    [Abstract] [Full Text] [Related]

  • 3. Ramoplanin versus methicillin-resistant Staphylococcus aureus: in vitro experience.
    Brumfitt W, Maple PA, Hamilton-Miller JM.
    Drugs Exp Clin Res; 1990 Apr; 16(8):377-83. PubMed ID: 2097143
    [Abstract] [Full Text] [Related]

  • 4. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A, Colao MG, Orsi A, Dei R, Giganti E, Parenti F.
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
    Shonekan D, Mildvan D, Handwerger S.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649
    [Abstract] [Full Text] [Related]

  • 6. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V.
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [Abstract] [Full Text] [Related]

  • 7. Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci.
    Mini E, Novelli A, Mazzei T, Periti P.
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):256-60. PubMed ID: 2523807
    [Abstract] [Full Text] [Related]

  • 8. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Moorhouse EC, Mulvihill TE, Jones L, Mooney D, Falkiner FR, Keane CT.
    J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632
    [Abstract] [Full Text] [Related]

  • 9. In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients.
    Rolston KV, Dholakia N, Ho DH, LeBlanc B, Dvorak T, Streeter H.
    J Antimicrob Chemother; 1996 Aug; 38(2):265-9. PubMed ID: 8877541
    [Abstract] [Full Text] [Related]

  • 10. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
    Shibl AM, Ishag AH, Durgham SM.
    APMIS Suppl; 1988 Aug; 3():68-70. PubMed ID: 2972301
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
    Vedel G, Leruez M, Lémann F, Hraoui E, Ratovohery D.
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
    [Abstract] [Full Text] [Related]

  • 12. In-vitro activity of paldimycin against methicillin-resistant and susceptible isolates of Staphylococcus aureus and S. epidermidis.
    Pfaller MA, Bale M, Barrett M.
    J Antimicrob Chemother; 1987 Aug; 20(2):286-8. PubMed ID: 3667485
    [No Abstract] [Full Text] [Related]

  • 13. In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.
    Lawrence T, Rotstein C, Beam TR, Gorzynski EA, Amsterdam D.
    Antimicrob Agents Chemother; 1993 Apr; 37(4):896-900. PubMed ID: 8494388
    [Abstract] [Full Text] [Related]

  • 14. In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial.
    O'Hare MD, Ghosh G, Felmingham D, Grüneberg RN.
    J Antimicrob Chemother; 1990 Feb; 25(2):217-20. PubMed ID: 2139436
    [Abstract] [Full Text] [Related]

  • 15. In-vitro selection of resistance of Staphylococcus aureus to teicoplanin and vancomycin.
    Watanakunakorn C.
    J Antimicrob Chemother; 1990 Jan; 25(1):69-72. PubMed ID: 2138602
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of gram-positive cocci to paldimycin.
    Pohlod DJ, Saravolatz LD, Somerville MM.
    Antimicrob Agents Chemother; 1987 Jan; 31(1):104-7. PubMed ID: 3105438
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of ramoplanin on staphylococci.
    Francis J, Webster H, Newsom SW.
    Drugs Exp Clin Res; 1990 Jan; 16(9):457-60. PubMed ID: 2100247
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria.
    Citron DM, Merriam CV, Tyrrell KL, Warren YA, Fernandez H, Goldstein EJ.
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2334-8. PubMed ID: 12821492
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria.
    Hassan H, O'Hare MD, Felmingham D.
    Singapore Med J; 1990 Feb; 31(1):56-8. PubMed ID: 2139737
    [Abstract] [Full Text] [Related]

  • 20. In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.
    Biavasco F, Manso E, Varaldo PE.
    Antimicrob Agents Chemother; 1991 Jan; 35(1):195-7. PubMed ID: 1826593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.